Recombinant Human CEACAM3 (C-6His)

Description

EnkiLife provides the Recombinant Human CEACAM3 (C-6His) protein,aslo know as Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3,Carcinoembryonic Antigen CGM1,CD66d,CEACAM3,CD66D,CGM1, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 is produced by our Mammalian expression system and the target gene encoding Lys35-Gly155 is expressed with a 6His tag at the C-terminus.Accession:P40198. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:14.13 KDa. Background:Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) belongs to the immunoglobulin superfamily and CEA family. CEACAM3 was originally described in bile ducts of liver as biliary glycoprotein. Subsequently, it was found to be a cell-cell adhesion molecule detected on leukocytes, epithelia, and endothelia. CEACAM3 mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. In addition, it is associated with the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses.